Knocking down TAGLN2 may present as a target in breast cancer patients, based on reports that TAGLN2 knockdown increases DNA damage and sensitizes gastric cancer cells to chemotherapy and radiation [116]. The gene discussed is TAGLN2; the disease is gastric cancer.